281 related articles for article (PubMed ID: 34706042)
1. Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais.
Silva RBD; Silva TPRD; Sato APS; Lana FCF; Gusmão JD; Souza JFA; Matozinhos FP
Rev Saude Publica; 2021; 55():66. PubMed ID: 34706042
[TBL] [Abstract][Full Text] [Related]
2. Adverse events following immunization in pregnant women from Minas Gerais.
Silveira IOD; Silva TPRD; Luvisaro BMO; Silva RBD; Gusmão JD; Vimieiro AM; Oliveira VC; Souza KCR; Faria APV; Matozinhos FP
Rev Saude Publica; 2021; 55():24. PubMed ID: 34008780
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.
Supangat ; Sakinah EN; Nugraha MY; Qodar TS; Mulyono BW; Tohari AI
BMC Pharmacol Toxicol; 2021 Oct; 22(1):58. PubMed ID: 34641944
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological Evaluation of Events Allegedly Attributable to COVID-19 Vaccination: A Cross-Sectional Study in the Brazilian Amazon.
Silva MSO; Sotelo GM; Fernandes FP; Valentim LA; Paula MS; Quaresma TC; Dias MJDR; Esquerdo GAM; Moraes WP; Oliveira SMS
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543090
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
Puspitarani F; Sitaresmi MN; Ahmad RA
Front Public Health; 2022; 10():999354. PubMed ID: 36388348
[TBL] [Abstract][Full Text] [Related]
7. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
[TBL] [Abstract][Full Text] [Related]
9. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
Front Immunol; 2022; 13():965171. PubMed ID: 36263025
[TBL] [Abstract][Full Text] [Related]
10. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
Gold MS; Lincoln G; Cashman P; Braunack-Mayer A; Stocks N
Vaccine; 2021 Jan; 39(2):332-342. PubMed ID: 33279317
[TBL] [Abstract][Full Text] [Related]
12. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
Gao D; Dong G; Zhu L; Jia N; Sun B
Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
[TBL] [Abstract][Full Text] [Related]
13. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
García-Grimshaw M; Ceballos-Liceaga SE; Hernández-Vanegas LE; Núñez I; Hernández-Valdivia N; Carrillo-García DA; Michel-Chávez A; Galnares-Olalde JA; Carbajal-Sandoval G; Del Mar Saniger-Alba M; Carrillo-Mezo RA; Fragoso-Saavedra S; Espino-Ojeda A; Blaisdell-Vidal C; Mosqueda-Gómez JL; Sierra-Madero J; Pérez-Padilla R; Alomía-Zegarra JL; López-Gatell H; Díaz-Ortega JL; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
Clin Immunol; 2021 Aug; 229():108786. PubMed ID: 34147649
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D
Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278
[TBL] [Abstract][Full Text] [Related]
15. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016).
Mauro AB; Fernandes EG; Miyaji KT; Arantes BA; Valente MG; Sato HK; Sartori AMC
Rev Inst Med Trop Sao Paulo; 2019 Sep; 61():e43. PubMed ID: 31531621
[TBL] [Abstract][Full Text] [Related]
16. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
[TBL] [Abstract][Full Text] [Related]
17. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana.
Marfoh K; Samba A; Okyere E; Acheampong F; Owusu E; Darko DNA; Zakariah J; Mensa H; Aidoo E; Mohammed Y
BMJ Open; 2023 Jun; 13(6):e061643. PubMed ID: 37380201
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of adverse events associated with 145 000 doses of COVID-19 vaccines in a Brazilian municipality.
Martins-Filho PR; Santana RRR; Cavalcante TF; Barboza WS; de Souza MF; Góes MAO; Fontes ÂMB; da Silva MEL; Tanajura DM
Rev Panam Salud Publica; 2022; 46():e110. PubMed ID: 36016838
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.
Ferrara F; Mancaniello C; Varriale A; Sorrentino S; Zovi A; Nava E; Trama U; Boccellino M; Vitiello A
Clin Drug Investig; 2022 Dec; 42(12):1065-1074. PubMed ID: 36274082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
